4//SEC Filing
Doyle Anthony 4
Accession 0001127602-21-031121
CIK 0000882796other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:59 PM ET
Size
6.8 KB
Accession
0001127602-21-031121
Insider Transaction Report
Form 4
Doyle Anthony
Chief Financial Officer
Transactions
- Award
Common Stock
2021-12-14+115,000→ 208,719 total - Award
Emp. Stock Option (Right to Buy)
2021-12-14+164,000→ 164,000 totalExercise: $11.43From: 2022-12-14Exp: 2031-12-14→ Common Stock (164,000 underlying)
Footnotes (2)
- [F1]Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- [F2]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001808688
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:59 PM ET
- Size
- 6.8 KB